Exploiting and Understanding Chemical Biotransformations in the Human Microbiome
Organizer(s): Peter J. Turnbaugh, Curtis Huttenhower and Michael A. FischbachDate: April 01 - 06, 2014
Location: Big Sky Resort, Big Sky, MT, USA
The aggregate genomes of the trillions of microorganisms associated with the human body, the gut microbiome, extend our own human metabolism through transforming our diet and xenobiotic compounds, including host-targeted drugs and antibiotics. Furthermore, our microbial consortia encode a diverse array of biosynthetic machinery, making them an ideal source of novel natural products. This conference explores the major challenges that are emerging from this new area of study: 1) The biotransformation and resistance to therapeutics; 2) The discovery of natural products from microorganisms, in the context of the human microbiome and other systems; 3) Computational approaches to understanding microbial metabolism and biosynthesis; 4) The potential for synthetic biology to engineer microbiomes; 5) Therapeutic approaches to manipulate the microbiome; 6) Host-microbial signaling mechanisms; and 7) The consequences of microbial biotransformations and toxicity on host health and disease. This conference should foster long-lasting collaborative partnerships between individuals with wide-ranging expertise from both academia and industry. It incorporates the introduction of state-of-the-art techniques to existing areas of research, along with an attempt to identify general biological themes that influence multiple areas of research.
Scholarship Deadline: December 5 2013
Discounted Abstract Deadline: December 5 2013
Abstract Deadline: January 9 2014
Discounted Registration Deadline: February 3 2014
We gratefully acknowledge additional support for this conference from:
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:
We gratefully acknowledge the generous grant for this conference provided by:National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Grant No. 5R13DK084688-05
The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.